Cronos Group (CRON) Competitors

$2.74 +0.01 (+0.37%)

Closing price 04:00 PM Eastern

Extended Trading

$2.72 -0.02 (-0.55%)

As of 05:18 PM Eastern

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

Should you buy Cronos Group stock or one of its competitors? MarketBeat compares Cronos Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Cronos Group compare to Aurora Cannabis?

Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

Cronos Group has a net margin of -1.14% compared to Aurora Cannabis' net margin of -23.46%. Aurora Cannabis' return on equity of -0.04% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Aurora Cannabis	-23.46%	-0.04%	-0.03%

Aurora Cannabis has higher revenue and earnings than Cronos Group. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$159.54M	6.46	-$9.45M	$0.01	274.00
Aurora Cannabis	$373.12M	0.53	$1.63M	-$1.08	N/A

Cronos Group has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.51, indicating that its share price is 49% less volatile than the broader market.

Cronos Group currently has a consensus price target of $2.30, suggesting a potential downside of 16.06%. Given Cronos Group's stronger consensus rating and higher possible upside, research analysts clearly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Cronos Group had 9 more articles in the media than Aurora Cannabis. MarketBeat recorded 13 mentions for Cronos Group and 4 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.96 beat Cronos Group's score of 0.86 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Cronos Group beats Aurora Cannabis on 10 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Canopy Growth?

Cronos Group (NASDAQ:CRON) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.2% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cronos Group has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market.

In the previous week, Cronos Group had 6 more articles in the media than Canopy Growth. MarketBeat recorded 13 mentions for Cronos Group and 7 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.95 beat Cronos Group's score of 0.86 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Canopy Growth	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Canopy Growth	2 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has higher earnings, but lower revenue than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$159.54M	6.46	-$9.45M	$0.01	274.00
Canopy Growth	$278.39M	1.55	-$429.86M	-$1.30	N/A

Cronos Group has a net margin of -1.14% compared to Canopy Growth's net margin of -94.39%. Cronos Group's return on equity of -1.26% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Canopy Growth	-94.39%	-46.85%	-28.95%

Summary

Cronos Group beats Canopy Growth on 13 of the 15 factors compared between the two stocks.

How does Cronos Group compare to Organigram Global?

Organigram Global (NASDAQ:OGI) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Comparatively, 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Organigram Global has a beta of 1.5, meaning that its share price is 50% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

In the previous week, Cronos Group had 1 more articles in the media than Organigram Global. MarketBeat recorded 13 mentions for Cronos Group and 12 mentions for Organigram Global. Cronos Group's average media sentiment score of 0.86 beat Organigram Global's score of 0.18 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram Global	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cronos Group	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 16.06%. Given Cronos Group's higher possible upside, analysts clearly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Cronos Group has lower revenue, but higher earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$279.99M	0.55	-$17.70M	-$0.13	N/A
Cronos Group	$159.54M	6.46	-$9.45M	$0.01	274.00

Cronos Group has a net margin of -1.14% compared to Organigram Global's net margin of -9.22%. Cronos Group's return on equity of -1.26% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.49%	-8.99%
Cronos Group	-1.14%	-1.26%	-1.20%

Summary

Cronos Group beats Organigram Global on 11 of the 15 factors compared between the two stocks.

How does Cronos Group compare to SNDL?

SNDL (NASDAQ:SNDL) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Cronos Group has a net margin of -1.14% compared to SNDL's net margin of -1.19%. SNDL's return on equity of -1.02% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
Cronos Group	-1.14%	-1.26%	-1.20%

SNDL has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

8.7% of Cronos Group shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Cronos Group had 12 more articles in the media than SNDL. MarketBeat recorded 13 mentions for Cronos Group and 1 mentions for SNDL. SNDL's average media sentiment score of 1.89 beat Cronos Group's score of 0.86 indicating that SNDL is being referred to more favorably in the media.

Company	Overall Sentiment
SNDL	Very Positive
Cronos Group	Positive

Cronos Group has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.55	-$11.29M	-$0.03	N/A
Cronos Group	$159.54M	6.46	-$9.45M	$0.01	274.00

SNDL presently has a consensus price target of $5.00, indicating a potential upside of 242.47%. Cronos Group has a consensus price target of $2.30, indicating a potential downside of 16.06%. Given SNDL's higher probable upside, research analysts clearly believe SNDL is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Cronos Group beats SNDL on 10 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Tilray Brands?

Cronos Group (NASDAQ:CRON) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends.

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 9.4% of Tilray Brands shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 0.8% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$159.54M	6.46	-$9.45M	$0.01	274.00
Tilray Brands	$210.48M	3.05	-$2.19B	-$13.65	N/A

Cronos Group presently has a consensus price target of $2.30, indicating a potential downside of 16.06%. Tilray Brands has a consensus price target of $11.50, indicating a potential upside of 109.09%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

Cronos Group has a net margin of -1.14% compared to Tilray Brands' net margin of -156.51%. Cronos Group's return on equity of -1.26% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Tilray Brands	-156.51%	-3.31%	-2.42%

Cronos Group has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.94, indicating that its share price is 94% more volatile than the broader market.

In the previous week, Tilray Brands had 2 more articles in the media than Cronos Group. MarketBeat recorded 15 mentions for Tilray Brands and 13 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.86 beat Tilray Brands' score of 0.81 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Tilray Brands	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cronos Group beats Tilray Brands on 9 of the 16 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRON vs. The Competition

Export

Metric	Cronos Group	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.03B	$3.04B	$6.29B	$12.46B
Dividend Yield	N/A	1.96%	2.79%	5.30%
P/E Ratio	274.27	19.11	20.87	25.58
Price / Sales	6.46	278.37	521.63	63.56
Price / Cash	220.95	56.53	42.94	55.34
Price / Book	0.92	4.35	9.86	6.70
Net Income	-$9.45M	$72.19M	$3.55B	$333.77M
7 Day Performance	6.61%	-0.60%	-0.32%	0.45%
1 Month Performance	6.61%	0.25%	1.34%	4.06%
1 Year Performance	33.01%	46.24%	41.03%	36.21%

Cronos Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRON Cronos Group	1.6756 of 5 stars	$2.74 +0.4%	$2.30 -16.1%	+33.8%	$1.03B	$159.54M	274.27	450	Earnings Report Analyst Forecast
ACB Aurora Cannabis	1.1121 of 5 stars	$3.42 +0.3%	N/A	-35.3%	$201.55M	$246.72M	N/A	1,130
CGC Canopy Growth	2.1158 of 5 stars	$1.12 +0.9%	N/A	-24.8%	$448.58M	$225.65M	N/A	3,150
OGI Organigram Global	1.0333 of 5 stars	$1.31 -3.7%	N/A	-10.1%	$191.44M	$185.07M	9.36	1,139	News Coverage Earnings Report
SNDL SNDL	3.7479 of 5 stars	$1.43 -0.3%	$5.00 +249.7%	+6.8%	$369.36M	$677.32M	N/A	2,751	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRON) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Summary

How does Cronos Group compare to Canopy Growth?

Summary

How does Cronos Group compare to Organigram Global?

Summary

How does Cronos Group compare to SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Is CRON or ACB more profitable?

Which has stronger valuation and earnings, CRON or ACB?

Which has more risk and volatility, CRON or ACB?

Do analysts rate CRON or ACB?

Does the media favor CRON or ACB?

Do insiders & institutionals believe in CRON or ACB?

Summary

How does Cronos Group compare to Canopy Growth?

Do insiders & institutionals believe in CRON or CGC?

Which has more risk and volatility, CRON or CGC?

Does the media favor CRON or CGC?

Do analysts rate CRON or CGC?

Which has stronger valuation and earnings, CRON or CGC?

Is CRON or CGC more profitable?

Summary

How does Cronos Group compare to Organigram Global?

Do institutionals & insiders believe in OGI or CRON?

Which has more volatility and risk, OGI or CRON?

Does the media refer more to OGI or CRON?

Do analysts prefer OGI or CRON?

Which has preferable earnings & valuation, OGI or CRON?

Is OGI or CRON more profitable?

Summary

How does Cronos Group compare to SNDL?

Is SNDL or CRON more profitable?

Which has more volatility & risk, SNDL or CRON?

Do insiders and institutionals believe in SNDL or CRON?

Does the media refer more to SNDL or CRON?

Which has better earnings and valuation, SNDL or CRON?

Do analysts prefer SNDL or CRON?

Summary

How does Cronos Group compare to Tilray Brands?

Do institutionals and insiders believe in CRON or TLRY?

Which has preferable valuation & earnings, CRON or TLRY?

Do analysts prefer CRON or TLRY?

Is CRON or TLRY more profitable?

Which has more risk & volatility, CRON or TLRY?

Does the media prefer CRON or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools